Literature DB >> 15841389

Gly118Asp is a SCA14 founder mutation in the Dutch ataxia population.

Dineke S Verbeek1, Bart P C van de Warrenburg, F A M Hennekam, Dennis Dooijes, P F Ippel, Corien C Verschuuren-Bemelmans, H P H Kremer, Richard J Sinke.   

Abstract

Missense mutations in the PRKCG gene have recently been identified in spinocerebellar ataxia 14 (SCA14) patients; these include the Gly118Asp mutation that we found in a large Dutch autosomal dominant cerebellar ataxia (ADCA) family. We subsequently screened the current Dutch ataxia cohort (approximately 900 individuals) for SCA14 mutations in the Cys2 region of the PRKCG gene. We identified the Gly118Asp mutation in another eight individuals from five small families. Haplotype analysis identified a shared chromosomal region surrounding the SCA14 gene, and genealogical research was able to link all these ADCA patients to a single common ancestor. We therefore confirmed that the Gly118Asp mutation is a SCA14 founder mutation in the Dutch ADCA population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15841389     DOI: 10.1007/s00439-005-1278-z

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  11 in total

1.  Molecular analysis of autosomal dominant hereditary ataxias in the Indian population: high frequency of SCA2 and evidence for a common founder mutation.

Authors:  Q Saleem; S Choudhry; M Mukerji; L Bashyam; M V Padma; A Chakravarthy; M C Maheshwari; S Jain; S K Brahmachari
Journal:  Hum Genet       Date:  2000-02       Impact factor: 4.132

2.  Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis.

Authors:  B P C van de Warrenburg; R J Sinke; C C Verschuuren-Bemelmans; H Scheffer; E R Brunt; P F Ippel; J A Maat-Kievit; D Dooijes; N C Notermans; D Lindhout; N V A M Knoers; H P H Kremer
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

3.  Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study.

Authors:  C Gaspar; I Lopes-Cendes; S Hayes; J Goto; K Arvidsson; A Dias; I Silveira; P Maciel; P Coutinho; M Lima; Y X Zhou; B W Soong; M Watanabe; P Giunti; G Stevanin; O Riess; H Sasaki; M Hsieh; G A Nicholson; E Brunt; J J Higgins; M Lauritzen; L Tranebjaerg; V Volpini; N Wood; L Ranum; S Tsuji; A Brice; J Sequeiros; G A Rouleau
Journal:  Am J Hum Genet       Date:  2000-12-20       Impact factor: 11.025

4.  Spinocerebellar ataxia type 6: founder effect in Western Japan.

Authors:  M Mori; Y Adachi; M Kusumi; K Nakashima
Journal:  J Neurol Sci       Date:  2001-03-15       Impact factor: 3.181

5.  Evidence for a common Spinocerebellar ataxia type 7 (SCA7) founder mutation in Scandinavia.

Authors:  J Jonasson; V Juvonen; P Sistonen; J Ignatius; D Johansson; E J Björck; J Wahlström; A Melberg; G Holmgren; L Forsgren; M Holmberg
Journal:  Eur J Hum Genet       Date:  2000-12       Impact factor: 4.246

6.  Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.

Authors:  Dong-Hui Chen; Zoran Brkanac; Christophe L M J Verlinde; Xiao-Jian Tan; Laura Bylenok; David Nochlin; Mark Matsushita; Hillary Lipe; John Wolff; Magali Fernandez; P J Cimino; Thomas D Bird; Wendy H Raskind
Journal:  Am J Hum Genet       Date:  2003-03-17       Impact factor: 11.025

7.  Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14.

Authors:  Giovanni Stevanin; Valérie Hahn; Ebba Lohmann; Naima Bouslam; Michel Gouttard; Caroline Soumphonphakdy; Marie-Laure Welter; Elisabeth Ollagnon-Roman; Arnaud Lemainque; Merle Ruberg; Alexis Brice; Alexandra Durr
Journal:  Arch Neurol       Date:  2004-08

8.  Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma.

Authors:  Ichiro Yabe; Hidenao Sasaki; Dong-Hui Chen; Wendy H Raskind; Thomas D Bird; Isao Yamashita; Shoji Tsuji; Seiji Kikuchi; Kunio Tashiro
Journal:  Arch Neurol       Date:  2003-12

9.  Haplotype study in Dutch SCA3 and SCA6 families: evidence for common founder mutations.

Authors:  Dineke S Verbeek; Sytse J Piersma; Eric F A M Hennekam; Elly F Ippel; Peter L Pearson; Richard J Sinke
Journal:  Eur J Hum Genet       Date:  2004-06       Impact factor: 4.246

10.  Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family.

Authors:  B P C van de Warrenburg; D S Verbeek; S J Piersma; F A M Hennekam; P L Pearson; N V A M Knoers; H P H Kremer; R J Sinke
Journal:  Neurology       Date:  2003-12-23       Impact factor: 9.910

View more
  10 in total

Review 1.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

2.  A conserved eEF2 coding variant in SCA26 leads to loss of translational fidelity and increased susceptibility to proteostatic insult.

Authors:  Katherine E Hekman; Guo-Yun Yu; Christopher D Brown; Haipeng Zhu; Xiaofei Du; Kristina Gervin; Dag Erik Undlien; April Peterson; Giovanni Stevanin; H Brent Clark; Stefan M Pulst; Thomas D Bird; Kevin P White; Christopher M Gomez
Journal:  Hum Mol Genet       Date:  2012-09-21       Impact factor: 6.150

3.  A Japanese case of SCA14 with the Gly128Asp mutation.

Authors:  Hiroshi Morita; Kunihiro Yoshida; Kayo Suzuki; Shu-Ichi Ikeda
Journal:  J Hum Genet       Date:  2006-09-22       Impact factor: 3.172

4.  Spectrum and prevalence of autosomal dominant spinocerebellar ataxia in Hokkaido, the northern island of Japan: a study of 113 Japanese families.

Authors:  Rehana Basri; Ichiro Yabe; Hiroyuki Soma; Hidenao Sasaki
Journal:  J Hum Genet       Date:  2007-09-05       Impact factor: 3.172

5.  Clinical and neurophysiological profile of four German families with spinocerebellar ataxia type 14.

Authors:  Christos Ganos; Simone Zittel; Martina Minnerop; Odette Schunke; Christina Heinbokel; Christian Gerloff; Christine Zühlke; Peter Bauer; Thomas Klockgether; Alexander Münchau; Tobias Bäumer
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

Review 6.  Myoclonus-Ataxia Syndromes: A Diagnostic Approach.

Authors:  Malco Rossi; Sterre van der Veen; Marcelo Merello; Marina A J Tijssen; Bart van de Warrenburg
Journal:  Mov Disord Clin Pract       Date:  2020-11-03

Review 7.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

8.  Cognition is only minimally impaired in Spinocerebellar ataxia type 14 (SCA14): a neuropsychological study of ten Norwegian subjects compared to intrafamilial controls and population norm.

Authors:  Iselin Marie Wedding; Jeanette Koht; Espen Dietrichs; Nils Inge Landrø; Chantal M E Tallaksen
Journal:  BMC Neurol       Date:  2013-11-29       Impact factor: 2.474

9.  Genotype-phenotype correlations, dystonia and disease progression in spinocerebellar ataxia type 14.

Authors:  Viorica Chelban; Sarah Wiethoff; Bjørn K Fabian-Jessing; Nourelhoda A Haridy; Alaa Khan; Stephanie Efthymiou; Esther B E Becker; Emer O'Connor; Joshua Hersheson; Katrina Newland; Allan Thomas Hojland; Pernille A Gregersen; Suzanne G Lindquist; Michael B Petersen; Jørgen E Nielsen; Michael Nielsen; Nicholas W Wood; Paola Giunti; Henry Houlden
Journal:  Mov Disord       Date:  2018-03-30       Impact factor: 10.338

10.  Episodic ataxia and severe infantile phenotype in spinocerebellar ataxia type 14: expansion of the phenotype and novel mutations.

Authors:  Giovanna De Michele; Daniele Galatolo; Serena Galosi; Andrea Mignarri; Gabriella Silvestri; Carlo Casali; Vincenzo Leuzzi; Ivana Ricca; Melissa Barghigiani; Alessandra Tessa; Ettore Cioffi; Caterina Caputi; Vittorio Riso; Maria Teresa Dotti; Francesco Saccà; Giuseppe De Michele; Sirio Cocozza; Alessandro Filla; Filippo M Santorelli
Journal:  J Neurol       Date:  2021-07-22       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.